Clinical trial
Phase 3 Study on the Efficacy of Slow Release Insulin in Cystic Fibrosis Patients With Glucide Intolerance and Clinical Decay
NCT00687466 is registered in ClinicalTrials.gov with Fondazione per la ricerca sulla Fibrosi Cistica as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 3 Study on the Efficacy of Slow Release Insulin in Cystic Fibrosis Patients With Glucide Intolerance and Clinical Decay
- Lead sponsor
- Fondazione per la ricerca sulla Fibrosi Cistica
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- August 31, 2005
- Completion date
- October 31, 2009
- Enrollment
- 70 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.